Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study

HSS, Amar–Singh; Koh, Mia-Tuang; Kee Tan, Kah; Gaik Chan, Lee; Zhou, Lynn; Bouckenooghe, Alain; Crevat, Denis; Hutagalung, Yanee

doi:10.1016/j.vaccine.2013.10.013

Public

Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study

Published in Vaccine • Oct 14, 2013

Authors:

Amar–Singh HSS

Mia-Tuang Koh

Kah Kee Tan

Abstract

BACKGROUND: Dengue disease is a major public health problem across the Asia-Pacific region for which there is no licensed vaccine or treatment. We evaluated the safety and immunogenicity of Phase III lots of a candidate vaccine (CYD-TDV) in children in Malaysia. METHODS: In this observer-blind, plac...

Subject

Medicine

Reactogenicity

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!